CoChat

Simultaneous targeting of TGF-β/PD-L1 synergizes with radiotherapy by reprogramming the tumor microenvironment to overcome immune evasion

Open access
Lan, Yan, Moustafa, Mahmoud, Knoll, Maximilian, Xu, Chunxiao, Furkel, Jennifer, Lazorchak, Adam, Yeung, Tsz-Lun, Hasheminasab, Sayed-Mohammad, Jenkins, Molly H., Meister, Sarah, Yu, Huakui, Schlegel, Julian, Marelli, Bo, Tang, Zili, Qin, Guozhong, Klein, Carmen, Qi, Jin, Zhou, Cheng, Locke, George, Krunic, Damir, Derner, Melissa G., Schwager, Christian, Fontana, Rachel E., Kriegsmann, Katharina, Jiang, Feng, Rein, Katrin, Kriegsmann, Mark, Debus, Juergen, Lo, Kin-Ming, Abdollahi, Amir · 2021 · Cancer Cell
Cited by 201

The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.

Abstract

Localized radiotherapy (RT) induces an immunogenic antitumor response that is in part counterbalanced by activation of immune evasive and tissue remodeling processes, e.g., via upregulation of programmed cell death-ligand 1 (PD-L1) and transforming growth factor β (TGF-β). We report that a bifunctional fusion protein that simultaneously inhibits TGF-β and PD-L1, bintrafusp alfa (BA), effectively synergizes with radiotherapy, leading to superior survival in multiple therapy-resistant murine tumor models with poor immune infiltration. The BA + RT (BART) combination increases tumor-infiltrating leukocytes, reprograms the tumor microenvironment, and attenuates RT-induced fibrosis, leading to reconstitution of tumor immunity and regression of spontaneous lung metastases. Consistently, the beneficial effects of BART are in part reversed by depletion of cytotoxic CD8 + T cells. Intriguingly, targeting of the TGF-β trap to PD-L1 + endothelium and the M2/lipofibroblast-like cell compartment by BA attenuated late-stage RT-induced lung fibrosis. Together, the results suggest that the BART combination has the potential to eradicate therapy-resistant tumors while sparing normal tissue, further supporting its clinical translation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ccell.2021.08.008

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 18 references

Cited by

Metadata

Authors
Lan, Y., Moustafa, M., Knoll, M., Xu, C., Furkel, J., Lazorchak, A., Yeung, T.-L., Hasheminasab, S.-M., Jenkins, M. H., Meister, S., Yu, H., Schlegel, J., Marelli, B., Tang, Z., Qin, G., Klein, C., Qi, J., Zhou, C., Locke, G., Krunic, D., Derner, M. G., Schwager, C., Fontana, R. E., Kriegsmann, K., Jiang, F., Rein, K., Kriegsmann, M., Debus, J., Lo, K.-M., & Abdollahi, A.
Venue
Cancer Cell
Publisher
Elsevier BV
Published
2021-10
Volume
39
Issue
10
Pages
1388-1403.e10
ISSN
1535-6108 (ISSN-L)
OpenAlex
W3197402708
Cited by
201
References
18
FWCI
10.52
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.